Cryosite Limited

Equities

CTE

AU000000CTE1

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 08:02:29 2024-04-29 pm EDT			5-day change	1st Jan Change
0.85 ^AUD	-.--%		+4.94%	+40.50%

Feb. 22	Cryosite Limited Announces Board Changes	CI
Feb. 22	Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Cryosite Limited Announces Change in Company Secretary

January 10, 2022 at 11:57 pm EST

Cryosite Limited announced that Bryan Dulhunty will be stepping down from this role of Company Secretary effective 11 January 2022. Bryan has held the position of Company Secretary since the Company's IPO in 2002. Bryan will continue in his role as Chairman.

Following Bryan's resignation, the Company announced the appointment of Kim Bradley as Company Secretary effective 11 January 2022. Kim is a member of the Company Matters Pty Ltd. team (part of Link Group, including Link Market Services share registry). Kim will also be the primary person responsible for communications with the ASX pursuant to ASX Listing Rule 12.6.

Latest news about Cryosite Limited

Cryosite Limited Announces Board Changes	Feb. 22	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 22	CI
Cryosite Proposes Capital Return to Shareholders	Jan. 04	MT
Cryosite Limited Announces Director Changes	Dec. 07	CI
Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023	23-08-24	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-24	CI
Cryosite Limited Appoints Luis Antonio as an Independent Non-Executive Director	23-04-16	CI
Cryosite Limited Announces the Resignation of Bryan Dulhunty as Non Executive Director	23-02-28	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Cryosite Limited Announces Change of Company Secretary	23-01-17	CI
Cryosite Limited Announces Ordinary Dividend for the Year Ended June 30, 2022, Payable on October 14, 2022	22-08-25	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-25	CI
Cryosite Limited Announces Board Changes	22-03-09	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-22	CI
Cryosite Limited Announces Change in Company Secretary	22-01-10	CI
Cryosite Limited Appoints Steven Waller as Non-Executive Director	21-11-18	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-24	CI
Tranche Update on Cryosite Limited's Equity Buyback Plan announced on March 11, 2021.	21-05-17	CI
Cryosite Limited's Equity Buyback announced on March 11, 2021, has expired with 0 shares, representing 0% for AUD 0 million.	21-05-16	CI
Cryosite Limited authorizes a Buyback Plan.	21-03-10	CI
Cryosite Limited announces an Equity Buyback for 4,685,956 shares, representing 10% of its issued share capital.	21-03-10	CI
Cryosite Limited Announces Resignation of Bryan Dulhunty from Executive Chairman's Role to That of Non-Executive Chairman	20-10-14	CI
Cryosite Limited Announces the Appointment of John Hogg as Chief Executive Officer	20-10-14	CI
Cryosite Limited Reports Earnings Results for the Full Year Ended June 30, 2020	20-08-27	CI
Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2019	20-02-27	CI

Chart Cryosite Limited

Duration

Period

More charts

Company Profile

Cryosite Limited is engaged in providing outsourced clinical trials depot services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution and reverse logistics management. Its segments include Clinical trials and biological services logistics and Cord Blood and tissue storage. The Clinical trials and biological services logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, biological services and cell gene therapies depot services. Cord Blood and tissue storage segment provides storage of cord blood and tissue samples. Its facilities are purpose-built to store a range of biological materials, including Cell Banks (MCB, WCB), Mesenchymal Stromal Cell (MSC) Therapies, Tumour-Infiltrating Lymphocyte Therapies and others.

Sector

Healthcare Facilities & Services

Calendar

2024-08-22 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CRYOSITE LIMITED	+40.50%	26.94M
CVS HEALTH CORPORATION	-14.25%	85.35B
HCA HEALTHCARE, INC.	+14.46%	81.95B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.37%	28.99B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-11.40%	16.98B
FRESENIUS SE & CO. KGAA	-0.36%	16.85B
QUEST DIAGNOSTICS INCORPORATED	+0.22%	15.35B
FRESENIUS MEDICAL CARE AG	+4.32%	12.42B
EUROFINS SCIENTIFIC SE	-2.34%	11.88B
DAVITA INC.	+32.69%	12.19B

Other Healthcare Facilities & Services